fig1
![Circulating culprit or therapeutic bullseye: lipoprotein(a) in cardiovascular risk assessment and novel therapeutic prospects](https://image.oaes.cc/4d822b66-79e7-4bf1-92a6-e390952183a6/jca4035.fig.1.jpg)
Figure 1. Risk of clinical outcomes according to Lipoprotein(a) levels. Absolute risk per 10,000 person-years according to Lp(a) concentrations. Based on data from 70,286 white individuals in the Copenhagen General Population Study with a median of 7.4 years of follow-up.